A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

A monoclonal antibody (anti-B1) specific for a unique B cell surface differentiation antigen was used to characterize the malignant cells from patients with leukemias or lymphomas. All tumor cells from patients with lymphomas or chronic lymphocytic leukemias, bearing either monoclonal kappa lambda l...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Nadler, L M, Ritz, J, Hardy, R, Pesando, J M, Schlossman, S F, Stashenko, P
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 1981
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371580/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6969730/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110005
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!